Q1 2011

Filed May 13, 2011 · 10-Q · 43 days after period end · 0001140361-11-027419

Q1 2011 · 10-Q

Revenue—

Net Income

-$3.84M

no prior Q1 2010 on file

EPS Diluted

-$0.21

no prior Q1 2010 on file

Operating Income-$6,059,000—

Operating Cash Flow-$5,069,000—

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 13, 2011 · 43 d after period end

Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR